Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,0164 USD | -21,90% | +0,61% | -36,68% |
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 75 | 01-02-14 | |
Evan Wasoff
DFI | Director of Finance/CFO | 77 | - |
Jeremy Reeh
CTO | Chief Tech/Sci/R&D Officer | - | 26-10-18 |
Robert Goldfarb
COO | Chief Operating Officer | 69 | - |
Frank Manganella
PRN | Corporate Officer/Principal | 58 | 30-10-18 |
Joseph Aceto
PRN | Corporate Officer/Principal | 66 | 30-10-18 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Lindy Snider
BRD | Director/Board Member | 64 | 26-01-18 |
Chief Executive Officer | 75 | 01-02-14 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 67 472 196 | 30 966 703 ( 45,90 %) | 0 | 45,90 % |
Bedrijfsgegevens
Nexien BioPharma, Inc.
4340 East Kentucky Avenue Suite 206
80246, Glendale
+303 495 7583
http://www.nexienbiopharma.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
-36,68% | 1,11 mln. | |
+37,96% | 727 mld. | |
-7,81% | 354 mld. | |
+15,75% | 328 mld. | |
-0,44% | 277 mld. | |
+13,47% | 243 mld. | |
+7,35% | 205 mld. | |
-6,42% | 203 mld. | |
+3,90% | 164 mld. | |
-2,12% | 164 mld. |
- Beurs
- Aandelen
- Koers NXEN
- Onderneming Nexien BioPharma, Inc.